Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Email this article to a friend

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs

R Andrew Moore email, Sheena Derry email, Henry J McQuay email and John Paling email

Arthritis Research & Therapy 2008, 10:R20doi:10.1186/ar2373

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.